A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Top Cited Papers
- 1 December 2004
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 364 (9451), 2106-2112
- https://doi.org/10.1016/s0140-6736(04)17551-x
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health, Labour and Welfare
- Community Foundation of Louisville
- Mayo Foundation for Medical Education and Research
- National Multiple Sclerosis Society (RG3185-A-2)
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 18 references indexed in Scilit:
- Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosisMultiple Sclerosis Journal, 2003
- Neuromyelitis optica: what it is and what it might beThe Lancet, 2003
- Multiple sclerosis in the Japanese populationThe Lancet Neurology, 2003
- Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophyNature, 2002
- Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice GuidelinesNeurology, 2002
- Neuromyelitis OpticaSeminars in Neurology, 2002
- Clinical, CSF, and MRI findings in Devic's neuromyelitis optica.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Devic's neuromyelitis optica: A clinicopathological study of 8 patientsAnnals of Neurology, 1993
- Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: A prospective 2‐year follow‐up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CTNeurology, 1991
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983